Tapewire

Nasdaq · USD

ELVN

Enliven Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4024
SEC CIK
0001672619
Parsed reports
377

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202503
Jan 2026013
Feb 202603
Mar 202605
Apr 202603
May 202603
Jun 2026015
Jul 2026012
Aug 202605
Sep 202606
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 29, 2024 Filed May 1, 2024 23:02 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 3,250 $2.48 $8,060.00
Disclosure

SEC source: 0001415889-24-011914 · form4-05012024_110511.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 18:50 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001415889-24-011707 · form4-04292024_100422.xml · derivative · entry 6

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,841

Underlying: Common Stock · 12,000 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 18:50 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 12,000 $16.89 $202,700.40
Disclosure

SEC source: 0001415889-24-011707 · form4-04292024_100422.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $16.5946 to $17.336. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 18:50 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 12,000 $1.12 $13,440.00
Disclosure

SEC source: 0001415889-24-011707 · form4-04292024_100422.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
April 15, 2024 Filed Apr 15, 2024 23:03 UTC SaleCommon Stock 80 $20.68 $1,654.18
Disclosure

SEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 3

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,155

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $20.64 to $20.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 15, 2024 Filed Apr 15, 2024 23:03 UTC SaleCommon Stock 1,190 $19.94 $23,728.96
Disclosure

SEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 2

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,235

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $19.61 to $20.5558. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,580 $0.00 Strike: $19.68 $0.00
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · derivative · entry 10

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,742

Underlying: Common Stock · 4,580 shares

Expires 2029-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F6 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC Exercise / conversionStock Option (right to buy) · Derivative 48,820 $0.00 Strike: $12.60 $0.00
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · derivative · entry 9

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,820 shares

Expires 2028-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F6 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC SaleCommon Stock 3,068 $25.21 $77,342.44
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 7

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,341

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $25.02 to $25.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC SaleCommon Stock 20,032 $25.00 $500,701.84
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 6

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,409

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $24.015 to $25.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC SaleCommon Stock 30,300 $23.14 $701,023.83
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 5

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,441

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC Exercise / conversionCommon Stock 4,580 $19.68 $90,134.40
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 4

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,741

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
April 11, 2024 Filed Apr 12, 2024 22:23 UTC Exercise / conversionCommon Stock 48,820 $12.60 $615,132.00
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 3

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 19:06 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001415889-24-010830 · form4-04152024_110409.xml · derivative · entry 4

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 230,550

Underlying: Common Stock · 30,000 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 19:06 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 30,000 $25.04 $751,332.00
Disclosure

SEC source: 0001415889-24-010830 · form4-04152024_110409.xml · nonDerivative · entry 2

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 19:06 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
Exercise / conversionCommon Stock 30,000 $1.12 $33,600.00
Disclosure

SEC source: 0001415889-24-010830 · form4-04152024_110409.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 19:05 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (right to buy) · Derivative 47,709 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001415889-24-010828 · form4-04152024_110408.xml · derivative · entry 6

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 212,841

Underlying: Common Stock · 47,709 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 19:05 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
SaleCommon Stock 47,709 $25.04 $1,194,700.15
Disclosure

SEC source: 0001415889-24-010828 · form4-04152024_110408.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 19:05 UTC
Kintz SamuelDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 47,709 $1.12 $53,434.08
Disclosure

SEC source: 0001415889-24-010828 · form4-04152024_110408.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,709

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:06 UTC
Patel AnishCHIEF OPERATING OFFICER
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 14,903 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-010831 · form4-04152024_110448.xml · derivative · entry 4

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,717

Underlying: Common Stock · 14,903 shares

Expires 2031-03-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F4 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 14, 2021.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:06 UTC
Patel AnishCHIEF OPERATING OFFICER
SaleCommon Stock 17,500 $25.03 $438,098.50
Disclosure

SEC source: 0001415889-24-010831 · form4-04152024_110448.xml · nonDerivative · entry 2

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:06 UTC
Patel AnishCHIEF OPERATING OFFICER
Exercise / conversionCommon Stock 14,903 $2.48 $36,959.44
Disclosure

SEC source: 0001415889-24-010831 · form4-04152024_110448.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 14,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-010827 · form4-04152024_110419.xml · derivative · entry 4

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225,370

Underlying: Common Stock · 14,000 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 10,223 $25.04 $255,969.61
Disclosure

SEC source: 0001415889-24-010827 · form4-04152024_110419.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $24.69 to $25.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 3,777 $23.88 $90,179.27
Disclosure

SEC source: 0001415889-24-010827 · form4-04152024_110419.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,223

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $23.65 to $24.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:04 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 14,000 $2.48 $34,720.00
Disclosure

SEC source: 0001415889-24-010827 · form4-04152024_110419.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:03 UTC SaleCommon Stock 649 $25.00 $16,225.00
Disclosure

SEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 4

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 28,567

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023.

F5 · ownership.nature: The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:03 UTC SaleCommon Stock 5,045 $25.03 $126,279.38
Disclosure

SEC source: 0001415889-24-010825 · form4-04152024_110425.xml · nonDerivative · entry 1

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138.425

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:02 UTC
Collins Helen LouiseCHIEF MEDICAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-010823 · form4-04152024_110437.xml · derivative · entry 3

Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 267,084

Underlying: Common Stock · 20,000 shares

Expires 2031-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F3 · derivative.exercise_date: The option, originally for 287,084 shares, vested as to one-fourth of the shares on June 17, 2022, and the remainder vest in 36 equal monthly installments thereafter.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:02 UTC
Collins Helen LouiseCHIEF MEDICAL OFFICER
SaleCommon Stock 20,000 $25.07 $501,478.00
Disclosure

SEC source: 0001415889-24-010823 · form4-04152024_110437.xml · nonDerivative · entry 2

Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 23:02 UTC
Collins Helen LouiseCHIEF MEDICAL OFFICER
Exercise / conversionCommon Stock 20,000 $2.48 $49,600.00
Disclosure

SEC source: 0001415889-24-010823 · form4-04152024_110437.xml · nonDerivative · entry 1

Collins Helen Louise · CIK 0001701247 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 22:23 UTC Exercise / conversionStock Option (right to buy) · Derivative 13,600 $0.00 Strike: $12.60 $0.00
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · derivative · entry 8

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,820

Underlying: Common Stock · 13,600 shares

Expires 2028-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F6 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 22:23 UTC SaleCommon Stock 13,600 $21.01 $285,744.16
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 2

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,341

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.00 to $21.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 22:23 UTC Exercise / conversionCommon Stock 13,600 $12.60 $171,360.00
Disclosure

SEC source: 0001415889-24-010777 · form4-04122024_100442.xml · nonDerivative · entry 1

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
April 08, 2024 Filed Apr 11, 2024 00:39 UTC GrantStock Option (right to buy) · Derivative 37,882 $0.00 Strike: $18.30 $0.00
Disclosure

SEC source: 0001415889-24-010678 · form4-04112024_120413.xml · derivative · entry 1

Kunkel Lori Anne · CIK 0001536368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,882

Underlying: Common Stock · 37,882 shares

Expires 2034-04-08

F1 · derivative.exercise_date: 1/36th of the shares subject to the option will vest on May 8, 2024 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.

Read SEC document
April 08, 2024 Filed Apr 11, 2024 00:35 UTC
Patel AnishCHIEF OPERATING OFFICER
SaleCommon Stock 544 $19.40 $10,552.46
Disclosure

SEC source: 0001415889-24-010676 · form4-04112024_120405.xml · nonDerivative · entry 2

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,597

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $19.245 to $19.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 08, 2024 Filed Apr 11, 2024 00:35 UTC
Patel AnishCHIEF OPERATING OFFICER
SaleCommon Stock 4,331 $18.50 $80,134.33
Disclosure

SEC source: 0001415889-24-010676 · form4-04112024_120405.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,141

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $18.19 to $19.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 04, 2024 Filed Apr 9, 2024 00:40 UTC Exercise / conversionStock Option (right to buy) · Derivative 3,485 $0.00 Strike: $12.60 $0.00
Disclosure

SEC source: 0001415889-24-010520 · form4-04092024_120438.xml · derivative · entry 3

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,420

Underlying: Common Stock · 3,485 shares

Expires 2028-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Read SEC document
April 04, 2024 Filed Apr 9, 2024 00:40 UTC SaleCommon Stock 3,485 $19.15 $66,729.39
Disclosure

SEC source: 0001415889-24-010520 · form4-04092024_120438.xml · nonDerivative · entry 2

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,341

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.05 to $19.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 04, 2024 Filed Apr 9, 2024 00:40 UTC Exercise / conversionCommon Stock 3,485 $12.60 $43,911.00
Disclosure

SEC source: 0001415889-24-010520 · form4-04092024_120438.xml · nonDerivative · entry 1

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,826

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:30 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001415889-24-010228 · form4-04042024_010402.xml · derivative · entry 6

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,550

Underlying: Common Stock · 12,000 shares

Expires 2030-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:30 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 71 $19.36 $1,374.40
Disclosure

SEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 4

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $19.355 to $19.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:30 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 9,577 $18.80 $180,083.99
Disclosure

SEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 3

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $18.35 to $19.325. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:30 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 2,352 $17.72 $41,687.32
Disclosure

SEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 2

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,648

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.335 to $18.255. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 21:30 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
Exercise / conversionCommon Stock 12,000 $1.12 $13,440.00
Disclosure

SEC source: 0001415889-24-010228 · form4-04042024_010402.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 01:32 UTC Exercise / conversionStock Option (right to buy) · Derivative 3,143 $0.00 Strike: $5.52 $0.00
Disclosure

SEC source: 0001415889-24-010232 · form4-04042024_010458.xml · derivative · entry 5

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,428

Underlying: Common Stock · 3,143 shares

Expires 2032-01-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F5 · derivative.exercise_date: The option, originally for 32,849 shares, which share amount reflects the Stock Split, vested as to one-fourth of the shares on January 28, 2023, and the remainder of the shares vest in 12 equal quarterly installments thereafter.

F4 · balance_after: The number of shares beneficially owned reflect the 1-for-4 reverse stock split of the Issuer's Common Stock effected February 23, 2023 (the "Stock Split").

Read SEC document
April 01, 2024 Filed Apr 4, 2024 01:32 UTC Exercise / conversionStock Option (right to buy) · Derivative 94 $0.00 Strike: $12.60 $0.00
Disclosure

SEC source: 0001415889-24-010232 · form4-04042024_010458.xml · derivative · entry 4

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,905

Underlying: Common Stock · 94 shares

Expires 2028-10-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F3 · derivative.exercise_date: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

F4 · balance_after: The number of shares beneficially owned reflect the 1-for-4 reverse stock split of the Issuer's Common Stock effected February 23, 2023 (the "Stock Split").

Read SEC document
April 01, 2024 Filed Apr 4, 2024 01:32 UTC SaleCommon Stock 3,237 $19.08 $61,758.40
Disclosure

SEC source: 0001415889-24-010232 · form4-04042024_010458.xml · nonDerivative · entry 3

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,341

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 01:32 UTC Exercise / conversionCommon Stock 3,143 $5.52 $17,349.36
Disclosure

SEC source: 0001415889-24-010232 · form4-04042024_010458.xml · nonDerivative · entry 2

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 01:32 UTC Exercise / conversionCommon Stock 94 $12.60 $1,184.40
Disclosure

SEC source: 0001415889-24-010232 · form4-04042024_010458.xml · nonDerivative · entry 1

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,435

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.